DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP THERAPEUTIC 7400 MBq

DRAXIMAGE Sodium Iodide I131 Capsules are a therapeutic radioactive medication used for targeted treatment. This oral capsule, with a strength of 7400 MBq, is manufactured by Jubilant DraxImage Inc. in Canada.

Sodium Iodide I131 Capsules are primarily used in therapeutic applications to target specific conditions. This radioactive medication is often utilized in the treatment of certain thyroid-related issues, leveraging the properties of iodine-131 for its intended effects. The capsules are designed for oral administration, providing a targeted approach to therapy.

The effects of Sodium Iodide I131 Capsules are primarily focused on the thyroid gland. Users may experience a range of effects, including those related to the targeted treatment of thyroid conditions. It is important to follow medical guidance when using this medication to ensure proper administration and monitoring.

When handling Sodium Iodide I131 Capsules, it is crucial to follow safety protocols due to the radioactive nature of the medication. Proper storage and disposal are essential to minimize exposure. Users should be aware of the potential risks and take necessary precautions to ensure safe use.

Sodium Iodide I131 Capsules may interact with certain medications and substances. It is important to consult with a healthcare provider to understand potential interactions, especially with other radioactive treatments or medications that affect thyroid function. Alcohol and certain dietary supplements may also impact the effectiveness of the capsules.